Search / Trial NCT00002064

Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

Launched by PALO ALTO MEDICAL FOUNDATION · Aug 30, 2001

Trial Information

Current as of December 06, 2024

Completed

Keywords

Sulfonamides Toxoplasmosis Aids Related Opportunistic Infections Pyrimethamine Drug Therapy, Combination Encephalitis Acquired Immunodeficiency Syndrome Clindamycin

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Exclusion Criteria
  • Co-existing Condition:
  • Patients with the following conditions are excluded:
  • Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy.
  • Patients with other opportunistic infections or brain diseases are excluded.
  • Patients with AIDS and cerebral toxoplasmosis.

About Palo Alto Medical Foundation

Palo Alto Medical Foundation (PAMF) is a leading healthcare organization dedicated to advancing medical research and improving patient care through innovative clinical trials. As a part of the Sutter Health network, PAMF combines cutting-edge technology with a patient-centered approach to deliver high-quality, evidence-based treatments. The foundation is committed to fostering collaboration among healthcare professionals and researchers, ensuring rigorous adherence to ethical standards and regulatory requirements. Through its diverse clinical trial portfolio, PAMF aims to contribute to medical knowledge and enhance therapeutic options for patients across a wide range of conditions.

Locations

Palo Alto, California, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials